Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > RLAY Relay Therapeutics > Detailed Quotes

RLAY Relay Therapeutics

23.000
-0.740-3.12%
Close 10/06 16:00 ET
23.0000.0000.00%
Post Mkt Price 10/06 16:01 ET
High
24.095
Open
23.720
Turnover
23.03M
Low
22.770
Pre Close
23.740
Volume
997.86K
Market Cap
2.76B
P/E(TTM)
Loss
52wk High
37.670
Shares
120.13M
P/E(Static)
Loss
52wk Low
12.650
Float Cap
2.02B
Bid/Ask %
42.86%
Historical High
64.370
Shs Float
87.73M
Volume Ratio
0.94
Historical Low
12.650
Dividend TTM
--
Div Yield TTM
--
P/B
3.54
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.14%
Amplitude
5.58%
Avg Price
23.080
Lot Size
1
Float Cap
2.02B
Bid/Ask %
42.86%
Historical High
64.370
Shs Float
87.73M
Volume Ratio
0.94
Historical Low
12.650
Dividend TTM
--
P/B
3.54
Dividend LFY
--
Turnover Ratio
1.14%
Amplitude
5.58%
Avg Price
23.080
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
CEO: Mr. Sanjiv K. Patel, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...